US-based BioGX has secured CE-IVD marking for its Flu A, Flu B, RSV automated test on Becton, Dickinson and Company's (BD) MAX system to detect influenza A, B and Respiratory Syncytial Virus (RSV).

The objective of the test is to simultaneously identify the presence of Flu A, Flu B and RSV RNA in nasopharyngeal swab samples collected from individuals at risk of infection.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Flu A, Flu B, RSV assay for the BD MA automated real-time PCR instrument is provided in a snap-in-tube format, called Sample-Ready.

"We listened closely to the needs of our customers and crafted these products to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into any laboratory running the BD MAX system."

BioGX offers all test-specific real-time PCR components lyophilized in a single tube.

This Sample-Ready tube snaps into the test-specific position on the BD MAX RNA/DNA extraction cartridge, which is supplied by BD.  

BioGX Sample-Ready assays offer clinical laboratories with the time and cost-savings unlike other complex systems. It enables minimum assay manipulation, simple workflow, and quick turnaround times.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Sample-Ready lyophilized reagent mixes are compatible with several automated sample extraction and qPCR systems.

 BioGX reagent technology offers the flexibility to run automated tests as singles or in batches to fit the requirements of a laboratory workflow.

BioGX CEO Shazi Iqbal said: "In developing the Sample-Ready family of assays, we listened closely to the needs of our customers and crafted these products to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into any laboratory running the BD MAX system.

"Additional diagnostic tests using this technology will be available soon to further extend our market reach."

Currently, the Flu A, Flu B, RSV assay for BD MAX is sold directly by BioGX and not available for sale in the US.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact